EMA-EP Regimen, as first line multiple agent chemotherapy in high risk GTD patients (stage II-IV).
Kohorn
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D031901:Gestational Trophoblastic Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging / Q000379:methods*; D011247:Pregnancy; D015203:Reproducibility of Results; D012307:Risk Factors; D009626:Terminology as Topic
D003609:Dactinomycin; D005047:Etoposide; D002945:Cisplatin; D008727:Methotrexate